Precision Optics Corp. Files 8-K on Officer/Director Changes
Ticker: POCI · Form: 8-K · Filed: Oct 3, 2025 · CIK: 867840
| Field | Detail |
|---|---|
| Company | Precision Optics Corporation, Inc. (POCI) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $275,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance, filing
TL;DR
POC is changing up its execs and board, filing 8-K on 9/29.
AI Summary
Precision Optics Corporation, Inc. filed an 8-K on October 3, 2025, reporting events as of September 29, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- PRECISION OPTICS CORPORATION, INC. (company) — Registrant
- September 29, 2025 (date) — Earliest event reported
- October 3, 2025 (date) — Filing date
FAQ
What specific officer or director positions were affected by the events reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and positions are not detailed in the provided excerpt.
Are there any new financial statements included with this 8-K filing?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item being reported.
What is the primary business of Precision Optics Corporation, Inc. according to the filing?
The company is classified under 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS' with SIC code 3845.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 29, 2025.
What is the state of incorporation for Precision Optics Corporation, Inc.?
The company is incorporated in Massachusetts (MA).
Filing Stats: 1,052 words · 4 min read · ~4 pages · Grade level 11.1 · Accepted 2025-10-03 16:15:47
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share POCI The Nasdaq Stock Ma
- $275,000 — compensated at an annual base salary of $275,000, will be eligible for an annual bonus u
Filing Documents
- poci_8k.htm (8-K) — 32KB
- poci_ex1001.htm (EX-10.1) — 11KB
- poci_ex1002.htm (EX-10.2) — 76KB
- poci_ex1003.htm (EX-10.3) — 25KB
- image_001.jpg (GRAPHIC) — 1KB
- 0001683168-25-007400.txt ( ) — 335KB
- poci-20250929.xsd (EX-101.SCH) — 3KB
- poci-20250929_lab.xml (EX-101.LAB) — 33KB
- poci-20250929_pre.xml (EX-101.PRE) — 22KB
- poci_8k_htm.xml (XML) — 3KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) and (e) On October 2, 2025, Precision Optics Corporation, Inc's (" POCI " or the " Company ") and Mr. Mahesh Lawande mutually agreed to terminate his employment with the Company as of October 31, 2025 (the " Termination Date "). Effective October 1, 2025, Mr. Lawande transitioned to the roll of "Advisor to the President" for the period through his Termination Date. On October 2, 2025, the Company and Mr. Lawande's entered into a Modification Agreement (the " Modification ") to his Employment Agreement dated March 30, 2023 by and between Mr. Lawande and the Company (the " Employment Agreement "), which Modification provides for the roll of "Advisor to the President" during the month of October 2025 and amends his severance period from six months to seven months following his Termination Date and waives any further right to additional notice under his Employment Agreement. The foregoing description of the Modification does not purport to be a complete statement of the parties' rights and obligations and is qualified in its entirety by reference to the full text of the Modification, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein. (c) and (e) As previously announced by the Company, effective as of October 1, 2025 (the "Start Date"), the Company appointed Mr. Joseph Traut, 54 years old, as the Company's Chief Operating Officer. Most recently, Mr. Traut was the VP of Operations for T2 Biosystems (2023-2025), VP of Technology Transfer at Lumira Dx (2021-2022) and VP of Manufacturing Solutions at Ximedica (now Veranex; 2017-2021), with additional positions prior to 2017 in manufacturing engineering, management and leadership. He has consulted to the Company since July 2025 on certain operational matters. Mr. Traut has a Master of Business Admini
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit Description 10.1 Modification Agreement dated October 2, 2025 by and between Precision Optics Corporation, Inc. and Mahesh Lawande. 10.2 Employment Agreement dated September 29, 2025 by and between Precision Optics Corporation, Inc. and Joseph W. Traut. 10.3 Non Competition Agreement dated September 29, 2025 by and between Precision Optics Corporation, Inc. and Joseph W. Traut. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRECISION OPTICS CORPORATION, INC. Dated: October 3, 2025 By: /s/ Joseph N. Forkey Name: Joseph N. Forkey Title: President 3